Advertisement
Document › Details
Indivumed GmbH. (12/12/21). "Press Release: Indivumed Appoints Dr. Stephan Schüller as CFO".
Organisation | Indivumed GmbH | |
Group | Indivumed (Group) | |
Organisation 2 | Bankhaus Lampe KG | |
Group | Oetker (Group) | |
Product | personalised medicine / precision medicine | |
Product 2 | banking | |
Person | Schüller, Stephan (Indivumed 202112– CFO before Bankhaus Lampe KG + Vereins- und Westbank AG) | |
Person 2 | Juhl, Hartmut (Indivumed 200701 CEO + founder) | |
Indivumed is pleased to announce that Dr. Stephan Schüller has joined Indivumed as Chief Financial Officer. With more than 30 years of experience as a business executive, professor, and board member, Dr. Schüller brings highly valuable knowledge and perspectives to Indivumed.
“It is a pleasure to support Indivumed in the current growth phase,” said Dr. Schüller. “Indivumed has a unique opportunity to realize better cancer care by data- and AI-driven precision oncology and it is a great privilege for me that I am allowed to contribute from a financial perspective realizing the full value of this amazing company.”
A prominent financial leader, Dr. Schüller studied business economics at the Westfälische Wilhelms-Universität in Münster, Germany. Since 1992, Schüller has taught business politics of financial institutions at the University of Duisburg-Essen and the Mercator School of Management.
Prior to joining Indivumed, Dr. Schüller was the CEO of Bankhaus Lampe KG in Düsseldorf and Vereins-und Westbank AG in Hamburg, respectively. Dr. Schüller was also a board member for several financial institutions, including Vereins-und Westbank AG in Hamburg and HypoVereinsbank AG (formerly Bayrische Vereinsbank) in München.
“I am honored that Stephan Schüller has decided to join Indivumed. With him we could win a worldwide highly respected financial expert to support Indivumed in becoming the leading AI- and data-driven company for precision oncology.” said Dr. Hartmut Juhl, Founder and CEO of Indivumed.
Record changed: 2023-06-05 |
Advertisement
More documents for Indivumed (Group)
- [1] Crown Bioscience, Inc.. (4/4/23). "Press Release: Crown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting Biobank". San Diego, CA....
- [2] Indivumed GmbH. (1/25/23). "Press Release: Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank". San Diego, CA & Hamburg....
- [3] Indivumed GmbH. (9/7/22). "Press Release: Indivumed and CellPhenomics Announce Partnership for Improved Cancer Patient Care". Berlin & Hamburg....
- [4] Indivumed GmbH. (1/17/22). "Press Release: Accelerated Drug Development and Personalised Treatments for Cancer. Indivumed Receives EU Funding from ERDF Structural Fund". Hamburg....
- [5] Indivumed GmbH. (8/10/21). "Press Release: Veraxa Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody Drugs". Heidelberg & Hamburg....
- [6] Indivumed GmbH. (6/2/21). "Press Release: Indivumed Launches the nRavel AI Platform for Cancer Research and Drug Development". Hamburg....
- [7] Indivumed GmbH. (5/17/21). "Press Release: Indivumed Joins KHR Biotec, Expands Partnership with University Medical Center Mainz". Hamburg....
- [8] Indivumed GmbH. (3/18/21). "Press Release: Indivumed Announces Expansion into Drug Development, Formation of Ix Therapeutics. Joint Venture with Xlife Sciences". Hamburg....
- [9] Indivumed GmbH. (1/26/21). "Press Release: Indivumed Appoints Roald Forsberg as New Chief Business Officer". Hamburg....
- [10] Evotec SE. (1/23/20). "Press Release: Evotec and Indivumed Announce Second Joint Drug Discovery Programme". Hamburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top